Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women

Hypertension
H KanaiY Matsuzawa

Abstract

We investigated the relationship between changes in blood pressure and fat distribution after a 12-week low-calorie diet in 26 obese hypertensive women whose average age was 50 +/- 13 years, mean body mass index was 33.7 +/- 3.1 kg/m2, and mean blood pressure was 112 +/- 9 mm Hg. As an index of intra-abdominal fat accumulation, we used the ratio of the intra-abdominal visceral fat area to subcutaneous fat area, determined by a computed tomographic section at the level of the umbilicus. Subjects lost a mean of 9.4 +/- 4.1 kg on a 1200-kcal (5040-kJ) diet for 12 weeks. Their mean blood pressure fell from 112 +/- 9 to 101 +/- 12 mm Hg (P < .001). The ratio of the visceral to subcutaneous fat area was significantly reduced after weight reduction from 0.56 +/- 0.33 to 0.45 +/- 0.27 (P < .02). Fasting plasma glucose and plasma glucose area after a 75-g oral glucose tolerance test also were significantly reduced by weight reduction. The change in mean blood pressure after weight reduction was not correlated with the change in body weight or body mass index but was correlated with the reduction in visceral fat area or ratio of visceral fat to subcutaneous fat area. Changes in mean blood pressure also were correlated with changes in fas...Continue Reading

References

Jul 22, 1978·British Medical Journal·L E RamsayJ Winchester
Jun 1, 1989·Annals of Internal Medicine·A N PeirisA H Kissebah
Aug 31, 1989·The New England Journal of Medicine·A P RocchiniM Martin
Aug 1, 1989·The American Journal of Cardiology·T NakajimaS Tarui
Aug 6, 1987·The New England Journal of Medicine·E FerranniniS Bevilacqua
May 1, 1987·European Heart Journal·S MacMahonM Higgins
Sep 1, 1987·Hypertension·A P RocchiniR P Kelch
Jun 1, 1986·The Journal of Clinical Endocrinology and Metabolism·V ManicardiE Ferrannini
Mar 1, 1985·The Journal of Clinical Investigation·M ModanZ Fuchs
Sep 1, 1985·Hypertension·C P LucasG M Reaven
Nov 1, 1985·Hypertension·A R ChristliebJ S Soeldner
Dec 1, 1985·Annals of Internal Medicine·G A Bray
Nov 1, 1970·Acta Medica Scandinavica·S A ForsbergS Berlind
Mar 1, 1983·Annals of Internal Medicine·E ReisinH M Batson
May 1, 1983·The American Journal of Medicine·F H MesserliE Frohlich
Sep 1, 1983·Hypertension·E D FrohlichF G Dunn
Sep 1, 1982·Hypertension·P BerchtoldM Berger
Jan 1, 1982·Journal of Chronic Diseases·E Reisin, E D Frohlich
Jun 12, 1958·The New England Journal of Medicine·L K DAHLR W CHRISTIE
May 1, 1964·The American Journal of Cardiology·M J KARVONENE J JAERVINEN
Dec 1, 1964·The American Journal of Cardiology·J K ALEXANDER

❮ Previous
Next ❯

Citations

Nov 20, 2003·Diabetes Research and Clinical Practice·Nobuyuki MiyatakeMasafumi Fujii
Jan 9, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·T B Chaston, J B Dixon
Nov 18, 2005·The New England Journal of Medicine·Jean-Pierre DesprésUNKNOWN Rimonabant in Obesity-Lipids Study Group
Oct 13, 2011·European Heart Journal·Tiberio M FrisoliFranz H Messerli
Jun 8, 2000·Annals of the New York Academy of Sciences·Y MatsuzawaT Nakamura
Oct 26, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·K ItohM Nakamura
Jul 18, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hiroyuki TakaseGenjiro Kimura
Jan 8, 2010·International Journal of Environmental Research and Public Health·Mark A PereiraRita Carreón
Jul 9, 2011·Journal of Atherosclerosis and Thrombosis·Yuji MatsuzawaTadashi Nakamura
Jan 12, 2007·Der Internist·A Mitchell, T Philipp
Nov 19, 2008·Stress : the International Journal on the Biology of Stress·J N Mann, J H Thakore
Mar 18, 2004·Current Medical Research and Opinion·Kohji Shirai
May 15, 2001·Clinical and Experimental Hypertension : CHE·H TakizawaK Shimamoto
May 27, 2011·Annals of Medicine·Ken KishidaIichiro Shimomura
Aug 28, 2013·Advances in Chronic Kidney Disease·Phyllis August
Feb 24, 2009·La Presse médicale·Xavier Girerd, Boris Hansel
Dec 3, 2014·JACC. Cardiovascular Imaging·Ravi V ShahMatthew A Allison
Apr 25, 2006·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·K Narkiewicz
Jun 2, 2006·Disease-a-month : DM·Ambika Babu, Leon Fogelfeld
Mar 10, 2005·The Medical Clinics of North America·Daisy ReyesPaul L Kimmel
May 25, 2015·American Journal of Obstetrics and Gynecology·Darcy R BarryThomas R Easterling
Nov 26, 2002·Obesity Research·Louis J Aronne, Karen R Segal
Jul 11, 2001·Obesity Research·Y W ParkD Gallagher
Jun 1, 2000·Obesity Research·I L Mertens, L F Van Gaal
May 24, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·R J H M VerheggenD H T Thijssen
May 6, 2006·FEBS Letters·Yuji Matsuzawa
Oct 1, 2016·Journal of the American College of Cardiology·Jane J LeeCaroline S Fox
Jul 12, 2008·American Journal of Hypertension·Charles AgyemangKarien Stronks
Feb 6, 2017·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C MerlottiA E Pontiroli
Mar 18, 2008·Arquivos brasileiros de endocrinologia e metabologia·Eduardo Cantoni RosaOsvaldo Kohlmann
Jun 9, 2017·Annals of Nutrition & Metabolism·Monica C SerraAlice S Ryan
Jan 30, 2004·American Journal of Physiology. Endocrinology and Metabolism·Kamal RahmouniCurt D Sigmund
Jun 1, 1997·The Journal of Clinical Endocrinology and Metabolism·M A MagiakouG P Chrousos
Aug 28, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Mohammed El HafidiGuadalupe Baños
Jun 29, 2016·Endocrine Research·Anawin SanguankeoUNKNOWN Fatty Liver Subgroup of the Look AHEAD Research Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.